Closed

Lecanemab Homecare Service

University College London Hospitals NHS FT · £816,000 · closes 26 Mar 2025

£816,000

Estimated value

Closed

Deadline

19 Feb 2025

Published

This tender has closed.

See what's open in health and social care services, or get contracts like this in your inbox each morning — free.

Set up free alertsOpen health and social care services tenders

About this contract

Direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only.

Key dates

Published19 Feb 2025
Submission deadline26 Mar 2025 Add to calendar ↓

Source

Source notice on Find a TenderView ↗

Lot — bid on it if it fits

This contract has one lot. Bid if it suits your firm.

The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient’s home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.Value not published

Who to contact

NameAaron Monaghan

Similar open tenders

Contains public sector information licensed under OGL v3.0